Archeus hopes to begin a Phase I trial of the PSMA-targeted agent in metastatic, castration-resistant prostate cancer later this year.

A tool developed by a scientist at UVA’s School of Nursing can help prostate cancer patients make important decisions when it comes to treatment options.

"Cancer changes you and everyone around you. That’s not a cliché. For me, it brought anxiety, urgency and openness." ...

When former president Joe Biden was diagnosed with prostate cancer, Randy Jones was not surprised. He’s a professor of ...

Alicia Morgans, MD, MPH, discusses new data that shows darolutamide with ADT significantly improves quality of life and delays pain for patients with metastatic hormone-sensitive prostate cancer.

The American Cancer Society said that prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the United States ...

Bronx Borough President Vanessa L. Gibson and the Morris Heights Health Center partnered with Anthem Blue Cross and Blue ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 15 best stocks to invest in for an 18 year old. On June 10, ...

Former President Joe Biden’s diagnosis with an aggressive form of prostate cancer has put a spotlight on prostate cancer ...